Merck & Co. Inc. Takes Position in Moderna, Inc. $MRNA
MarketBeat
Merck & Co. Inc. purchased a new stake in Moderna, Inc. (NASDAQ:MRNA - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 2,308,190 shares of the company's stock, valued at approximately $161,642,545,000. Moderna makes up
NASDAQ:MRNA